"Sutter Auburn Faith Hospital provides healthcare using the latest technologies while maintaining the small town friendliness and charm that make Auburn special.The Joint Commission recognizes this hospital as a Primary Stroke Center for their exceptional ability to provide high-quality stroke care."

During the past decade, Sutter Auburn Faith Hospital conducted 89 clinical trials. In the 10-year time frame, 89 clinical trials started and 46 clinical trials were completed, i.e. on average, 51.7% percent of trials that started reached the finish line to date. In the past 5 years, 26 clinical trials started and 43 clinical trials were completed. i.e. 165.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Sutter Auburn Faith Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 58 trials, followed by "SWOG Cancer Research Network" with 27 trials sponsored, "Alliance for Clinical Trials in Oncology" with 11 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 6 trials sponsored and "NRG Oncology" with 6 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Sutter Auburn Faith Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 56 trials as a collaborator, "NRG Oncology" with 17 trials as a collaborator, "Canadian Cancer Trials Group" with 8 trials as a collaborator, "Bayer" with 2 trials as a collaborator and "Genentech, Inc." with 2 trials as a collaborator. Other collaborators include 14 different institutions and companies that were collaborators in the rest 23 trials.

According to Clinical.Site data, the most researched conditions in "Sutter Auburn Faith Hospital" are "Recurrent Squamous Cell Lung Carcinoma" (9 trials), "Invasive Breast Carcinoma" (8 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (8 trials), "Recurrent Ovarian Carcinoma" (7 trials) and "Recurrent Fallopian Tube Carcinoma" (6 trials). Many other conditions were trialed in "Sutter Auburn Faith Hospital" in a lesser frequency.

Most popular intervention types in "Sutter Auburn Faith Hospital" are "Drug" (91 trials), "Other" (78 trials), "Biological" (52 trials), "Procedure" (34 trials) and "Radiation" (14 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (40 trials), "Quality-of-Life Assessment" (32 trials), "Computed Tomography" (19 trials), "Biospecimen Collection" (18 trials) and "Questionnaire Administration" (18 trials). Other intervention names were less common.

The vast majority of trials in "Sutter Auburn Faith Hospital" are 87 trials for "All" genders, 28 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Sutter Auburn Faith Hospital". undefined are not yet recruiting, 28 are recruiting, 59 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 20 completed trials in Sutter Auburn Faith Hospital, 4 suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Sutter Auburn Faith Hospital, 3 "Phase 1" clinical trials were conducted, 66 "Phase 2" clinical trials and 65 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".